XML 45 R47.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $) | 1 Months Ended | 12 Months Ended | 1 Months Ended | 14 Months Ended | 1 Months Ended | 3 Months Ended | 1 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | ---
Jul. 31, 2014 | Oct. 31, 2013 | Dec. 31, 2014 Segment | Dec. 31, 2013 | Dec. 31, 2012 | Apr. 30, 2013 | Aug. 31, 2014 | Feb. 28, 2015 | Dec. 31, 2014 | Dec. 31, 2011 | May 31, 2014 | Nov. 30, 2008 | Nov. 30, 2009 | Apr. 01, 2009
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of segments |  |  | 1 us-gaap_NumberOfOperatingSegments |  |  |  |  |  |  |  |  |  |  |
Accumulated deficit |  |  | $ (420,271,608)us-gaap_RetainedEarningsAccumulatedDeficit | $ (387,530,334)us-gaap_RetainedEarningsAccumulatedDeficit |  |  |  |  | $ (420,271,608)us-gaap_RetainedEarningsAccumulatedDeficit |  |  |  |  |
Maturity period for money market and highly liquid investments |  |  | 90 days |  |  |  |  |  |  |  |  |  |  |
Aggregate purchase price |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,135,000 stem_BusinessAcquisitionCostOfAcquiredEntityPurchasePriceNet
Percentage of purchase price allocated to goodwill |  |  | 42.00%stem_BusinessAcquisitionGoodwillAsPercentageOfPurchasePrice |  |  |  |  |  |  |  |  |  |  |
Impairment of Goodwill |  |  | 1,910,062 us-gaap_GoodwillImpairmentLoss |  |  |  |  |  |  |  |  |  |  |
Other intangible assets, net |  |  | 356,889 us-gaap_IntangibleAssetsNetExcludingGoodwill | 1,835,717 us-gaap_IntangibleAssetsNetExcludingGoodwill |  |  |  |  | 356,889 us-gaap_IntangibleAssetsNetExcludingGoodwill |  |  |  |  |
Impairment amount of intangible asset |  |  | 530,000 stem_ImpairmentsOfIntangibleAssetFiniteLived |  |  |  |  |  | 530,000 stem_ImpairmentsOfIntangibleAssetFiniteLived | 655,000 stem_ImpairmentsOfIntangibleAssetFiniteLived |  |  |  |
Value of patent |  |  | 0 stem_ContinuingValueOfPatent |  |  |  |  |  |  |  |  |  |  |
Fair value of certain lab equipment |  |  | 0 us-gaap_TangibleAssetImpairmentCharges | 0 us-gaap_TangibleAssetImpairmentCharges | 28,000 us-gaap_TangibleAssetImpairmentCharges |  |  |  |  |  |  |  |  |
Proceeds from loan |  |  | 5,775,543 us-gaap_ProceedsFromLoans |  |  |  |  |  |  |  |  |  |  |
Cash discount |  |  | 100,000 us-gaap_DebtInstrumentUnamortizedDiscount |  |  |  |  |  | 100,000 us-gaap_DebtInstrumentUnamortizedDiscount |  |  |  |  |
Term of loan |  |  | 3 years |  |  |  |  |  |  |  |  |  |  |
Annual interest rate on loan |  |  | 6.00%us-gaap_DebtInstrumentInterestRateEffectivePercentage |  |  |  |  |  | 6.00%us-gaap_DebtInstrumentInterestRateEffectivePercentage |  |  |  |  |
Final fee payment at the end of loan term |  |  | 1,000,000 stem_LoanFees |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ 2.17 us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | $ 1.80 us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 |  |  |  |  |  |  |  |  |  |  |  |
Initial carrying amount assigned to loan, net of discount |  |  | 9,512,000 stem_CarryingValueOfPurchasedLoans |  |  |  |  |  | 9,512,000 stem_CarryingValueOfPurchasedLoans |  |  |  |  |
Fair value allocated to warrant |  |  | 388,000 stem_FairValueAllocatedToWarrant |  |  |  |  |  | 388,000 stem_FairValueAllocatedToWarrant |  |  |  |  |
Note issuance costs |  |  | 117,000 us-gaap_DebtIssuanceCosts |  |  |  |  |  |  |  |  |  |  |
Deferred financing costs, discount and accretion percentage |  |  | 9.00%stem_DebtInstrumentAmortizedDiscountPercentage |  |  |  |  |  |  |  |  |  |  |
Common stock per unit |  |  | $ 1 stem_CommonStockPerUnit |  |  |  |  |  |  |  |  |  |  |
Warrants issued per unit |  |  | $ 1 stem_WarrantsIssuedPerUnit |  |  |  |  |  |  |  |  |  |  |
Number of shares issued upon Series B warrants exercise | 11,299,435 us-gaap_StockIssuedDuringPeriodSharesNewIssues | 12,845,500 us-gaap_StockIssuedDuringPeriodSharesNewIssues |  |  |  |  |  |  |  |  |  |  |  |
CIRM [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from loan |  |  | 5,775,543 us-gaap_ProceedsFromLoans / us-gaap_TypeOfArrangementAxis = stem_CaliforniaInstituteForRegenerativeMedicineMember |  |  |  |  |  |  |  |  |  |  |
Approval of fund by California Institute for Regenerative Medicine (CIRM) |  |  |  |  |  | 19,300,000 stem_ApprovalOfFundToCollaborators / us-gaap_TypeOfArrangementAxis = stem_CaliforniaInstituteForRegenerativeMedicineMember |  |  |  |  |  |  |  |
Aggregate proceeds from disbursement of the loan |  |  |  |  |  |  | 9,600,000 us-gaap_ProceedsFromIssuanceOfDebt / us-gaap_TypeOfArrangementAxis = stem_CaliforniaInstituteForRegenerativeMedicineMember |  |  |  |  |  |  |
Forgiveness of loan principal |  |  | 8,917,000 us-gaap_DebtInstrumentDecreaseForgiveness / us-gaap_TypeOfArrangementAxis = stem_CaliforniaInstituteForRegenerativeMedicineMember |  |  |  |  |  |  |  |  |  |  |
Accrued interest forgiven |  |  | 243,000 us-gaap_DebtInstrumentIncreaseAccruedInterest / us-gaap_TypeOfArrangementAxis = stem_CaliforniaInstituteForRegenerativeMedicineMember |  |  |  |  |  |  |  |  |  |  |
CIRM [Member] | Subsequent Events [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Repayment of aggregate loan proceeds received |  |  |  |  |  |  |  | 679,000 us-gaap_RepaymentsOfDebt / us-gaap_SubsequentEventTypeAxis = us-gaap_SubsequentEventMember / us-gaap_TypeOfArrangementAxis = stem_CaliforniaInstituteForRegenerativeMedicineMember |  |  |  |  |  |
Silicon Valley Bank [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from loan |  |  |  |  |  | 9,900,000 us-gaap_ProceedsFromLoans / us-gaap_RelatedPartyTransactionAxis = stem_SiliconValleyBankMember |  |  |  |  |  |  |  |
Cash discount |  |  |  |  |  | 100,000 us-gaap_DebtInstrumentUnamortizedDiscount / us-gaap_RelatedPartyTransactionAxis = stem_SiliconValleyBankMember |  |  |  |  |  |  |  |
Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of securities callable by warrants |  |  | 1,180,015 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember |  |  |  |  |  | 1,180,015 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember |  |  |  |  |
Warrant component | 0.85 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember | 0.5 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember |  |  |  |  |  |  |  |  |  |  |  |
Outstanding Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of warrant liability |  |  | 1,685,000 us-gaap_LiabilitiesFairValueDisclosure / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |  |  |  |  |  | 1,685,000 us-gaap_LiabilitiesFairValueDisclosure / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |  |  |  |  |
Marketable debt securities, current [Member] | Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments with maturities |  |  | 365 days or less |  |  |  |  |  |  |  |  |  |  |
Marketable securities, non-current [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments with maturities |  |  | Greater than 365 days |  |  |  |  |  |  |  |  |  |  |
Stem Cell Sciences Holdings Ltd [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate purchase price |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,135,000 stem_BusinessAcquisitionCostOfAcquiredEntityPurchasePriceNet / us-gaap_BusinessAcquisitionAxis = stem_StemCellSciencesHoldingsLtdMember
Percentage of purchase price allocated to goodwill |  |  |  |  |  |  |  |  | 42.00%stem_BusinessAcquisitionGoodwillAsPercentageOfPurchasePrice / us-gaap_BusinessAcquisitionAxis = stem_StemCellSciencesHoldingsLtdMember |  |  |  |  |
Impairment of Goodwill |  |  |  |  |  |  |  |  | $ 1,910,000 us-gaap_GoodwillImpairmentLoss / us-gaap_BusinessAcquisitionAxis = stem_StemCellSciencesHoldingsLtdMember |  |  |  |  |
Silicon Valley Bank Loan Agreement Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrant |  |  | 10 years |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants |  |  | $ 1.7034 us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 / us-gaap_ClassOfWarrantOrRightAxis = stem_SiliconValleyBankLoanAgreementWarrantMember |  |  |  |  |  | $ 1.7034 us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 / us-gaap_ClassOfWarrantOrRightAxis = stem_SiliconValleyBankLoanAgreementWarrantMember |  |  |  |  |
Warrant expiration period |  |  | April 2023 |  |  |  |  |  |  |  |  |  |  |
Silicon Valley Bank Loan Agreement Warrant [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of securities callable by warrants |  |  | 293,531 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights / us-gaap_ClassOfWarrantOrRightAxis = stem_SiliconValleyBankLoanAgreementWarrantMember / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember |  |  |  |  |  | 293,531 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights / us-gaap_ClassOfWarrantOrRightAxis = stem_SiliconValleyBankLoanAgreementWarrantMember / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember |  |  |  |  |
December 2011 Financing [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant component |  |  | 1 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember |  |  |  |  |  | 1 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember |  |  |  |  |
Number of shares issued upon Series B warrants exercise |  |  |  | 384,534 us-gaap_StockIssuedDuringPeriodSharesNewIssues / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember | 2,700,000 us-gaap_StockIssuedDuringPeriodSharesNewIssues / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember |  |  |  |  |  |  |  |  |
December 2011 Financing [Member] | Series A Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrant |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |
Number of securities callable by warrants |  |  |  |  |  |  |  |  |  | 8,000,000 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights / us-gaap_ClassOfWarrantOrRightAxis = stem_SeriesAWarrantsMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember |  |  |  |
Warrant component |  |  | 1 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight / us-gaap_ClassOfWarrantOrRightAxis = stem_SeriesAWarrantsMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember |  |  |  |  |  | 1 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight / us-gaap_ClassOfWarrantOrRightAxis = stem_SeriesAWarrantsMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember |  |  |  |  |
Number of warrants issued upon Series B warrants exercise |  |  |  |  | 2,700,000 stem_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued / us-gaap_ClassOfWarrantOrRightAxis = stem_SeriesAWarrantsMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember |  |  |  |  |  |  |  |  |
December 2011 Financing [Member] | Series A Warrants [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants |  |  |  |  |  |  |  |  |  | 1.40 us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 / us-gaap_ClassOfWarrantOrRightAxis = stem_SeriesAWarrantsMember / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember |  |  |  |
December 2011 Financing [Member] | Series B Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrant |  |  |  |  |  |  |  |  |  | 90 days |  |  |  |
Number of securities callable by warrants |  |  |  |  |  |  |  |  |  | 8,000,000 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights / us-gaap_ClassOfWarrantOrRightAxis = stem_SeriesBWarrantsMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember |  |  |  |
Exercise price of warrants |  |  |  |  |  |  |  |  |  | 1.25 us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 / us-gaap_ClassOfWarrantOrRightAxis = stem_SeriesBWarrantsMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember |  |  |  |
Number of warrants exercised |  |  |  |  | 2,700,000 stem_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised / us-gaap_ClassOfWarrantOrRightAxis = stem_SeriesBWarrantsMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember |  |  |  |  |  |  |  |  |
Number of warrants expired |  |  |  |  | 5,300,000 stem_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExpired / us-gaap_ClassOfWarrantOrRightAxis = stem_SeriesBWarrantsMember / us-gaap_SubsidiarySaleOfStockAxis = stem_DecemberTwoThousandElevenFinancingMember |  |  |  |  |  |  |  |  |
November 2008 Financing [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued |  |  |  |  |  |  |  |  |  |  | 1,034,483 stem_ClassOfWarrantOrRightIssued / us-gaap_SubsidiarySaleOfStockAxis = stem_NovemberTwoThousandEightFinancingMember |  |  |
November 2008 Financing [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of securities callable by warrants |  |  |  |  |  |  |  |  |  |  |  | 1,034,483 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember / us-gaap_SubsidiarySaleOfStockAxis = stem_NovemberTwoThousandEightFinancingMember |  |
Exercise price of warrants |  |  |  |  |  |  |  |  |  |  |  | 23.00 us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember / us-gaap_SubsidiarySaleOfStockAxis = stem_NovemberTwoThousandEightFinancingMember |  |
Warrant component |  |  |  |  |  |  |  |  |  |  |  | 0.75 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember / us-gaap_SubsidiarySaleOfStockAxis = stem_NovemberTwoThousandEightFinancingMember |  |
November 2008 Financing [Member] | Outstanding Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrant |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |
November 2009 Financing [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants |  |  | $ 15.00 us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 / us-gaap_SubsidiarySaleOfStockAxis = stem_NovemberTwoThousandNineFinancingMember |  |  |  |  |  | $ 15.00 us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 / us-gaap_SubsidiarySaleOfStockAxis = stem_NovemberTwoThousandNineFinancingMember |  |  |  |  |
November 2009 Financing [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of securities callable by warrants |  |  |  |  |  |  |  |  |  |  |  |  | 400,000 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember / us-gaap_SubsidiarySaleOfStockAxis = stem_NovemberTwoThousandNineFinancingMember |
Exercise price of warrants |  |  |  |  |  |  |  |  |  |  |  |  | 15.00 us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember / us-gaap_SubsidiarySaleOfStockAxis = stem_NovemberTwoThousandNineFinancingMember |
Warrant component |  |  |  |  |  |  |  |  |  |  |  |  | 0.40 us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight / us-gaap_StatementEquityComponentsAxis = us-gaap_CommonStockMember / us-gaap_SubsidiarySaleOfStockAxis = stem_NovemberTwoThousandNineFinancingMember |
November 2009 Financing [Member] | Outstanding Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrant |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |

X
- Definition Approval of fund to Collaborators + References No definition available. + Details
Name: | stem_ApprovalOfFundToCollaborators
Namespace Prefix: | stem_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business Acquisition Cost Of Acquired Entity Purchase Price Net + References No definition available. + Details
Name: | stem_BusinessAcquisitionCostOfAcquiredEntityPurchasePriceNet
Namespace Prefix: | stem_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Business acquisition goodwill as percentage of purchase price. + References No definition available. + Details
Name: | stem_BusinessAcquisitionGoodwillAsPercentageOfPurchasePrice
Namespace Prefix: | stem_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Carrying Value Of Purchased Loans + References No definition available. + Details
Name: | stem_CarryingValueOfPurchasedLoans
Namespace Prefix: | stem_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Cash And Cash Equivalents Maturity Period + References No definition available. + Details
Name: | stem_CashAndCashEquivalentsMaturityPeriod
Namespace Prefix: | stem_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Class Of Warrant Or Right Exercise Period Of Warrants Or Rights + References No definition available. + Details
Name: | stem_ClassOfWarrantOrRightExercisePeriodOfWarrantsOrRights
Namespace Prefix: | stem_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Class Of Warrant Or Right Issued + References No definition available. + Details
Name: | stem_ClassOfWarrantOrRightIssued
Namespace Prefix: | stem_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Class of warrant or right number of warrants or rights exercised + References No definition available. + Details
Name: | stem_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised
Namespace Prefix: | stem_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Class of warrant or right number of warrants or rights expired + References No definition available. + Details
Name: | stem_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExpired
Namespace Prefix: | stem_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Class of warrant or right number of warrants or rights issued + References No definition available. + Details
Name: | stem_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued
Namespace Prefix: | stem_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Common stock per unit. + References No definition available. + Details
Name: | stem_CommonStockPerUnit
Namespace Prefix: | stem_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Continuing value of patent. + References No definition available. + Details
Name: | stem_ContinuingValueOfPatent
Namespace Prefix: | stem_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Debt Instrument Amortized Discount Percentage + References No definition available. + Details
Name: | stem_DebtInstrumentAmortizedDiscountPercentage
Namespace Prefix: | stem_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair Value Allocated To Warrant + References No definition available. + Details
Name: | stem_FairValueAllocatedToWarrant
Namespace Prefix: | stem_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Impairments Of Intangible Asset Finite Lived + References No definition available. + Details
Name: | stem_ImpairmentsOfIntangibleAssetFiniteLived
Namespace Prefix: | stem_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Loan Fees + References No definition available. + Details
Name: | stem_LoanFees
Namespace Prefix: | stem_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Maturity of money market funds and investments. + References No definition available. + Details
Name: | stem_MaturityOfMoneyMarketFundsAndInvestments
Namespace Prefix: | stem_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expiration date of warrants + References No definition available. + Details
Name: | stem_WarrantExpiration
Namespace Prefix: | stem_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants issued per unit. + References No definition available. + Details
Name: | stem_WarrantsIssuedPerUnit
Namespace Prefix: | stem_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(2)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Subparagraph 2 -Article 4 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Decrease for amounts of indebtedness forgiven by the holder of the debt instrument. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(f)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph f -Article 4 + Details
Name: | us-gaap_DebtInstrumentDecreaseForgiveness
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Increase for accrued, but unpaid interest on the debt instrument for the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(f)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph f -Article 4 + Details
Name: | us-gaap_DebtInstrumentIncreaseAccruedInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_DebtInstrumentInterestRateEffectivePercentage
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400 + Details
Name: | us-gaap_DebtInstrumentUnamortizedDiscount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees). + References No definition available. + Details
Name: | us-gaap_DebtIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 + Details
Name: | us-gaap_GoodwillImpairmentLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph ((a)(1),(b)) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 + Details
Name: | us-gaap_IntangibleAssetsNetExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of financial and nonfinancial obligations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258 + Details
Name: | us-gaap_LiabilitiesFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. + References No definition available. + Details
Name: | us-gaap_NumberOfOperatingSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. + References No definition available. + Details
Name: | us-gaap_ProceedsFromIssuanceOfDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash received from principal payments made on loans related to operating activities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 + Details
Name: | us-gaap_ProceedsFromLoans
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations. + References No definition available. + Details
Name: | us-gaap_RepaymentsOfDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.31(a)(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_RetainedEarningsAccumulatedDeficit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2921-110230 + Details
Name: | us-gaap_TangibleAssetImpairmentCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=stem_StemCellSciencesHoldingsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CashAndCashEquivalentsAxis=stem_MarketableSecuritiesCurrentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CashAndCashEquivalentsAxis=stem_MarketableSecuritiesNoncurrentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=stem_SiliconValleyBankLoanAgreementWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=stem_SiliconValleyBankMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=stem_DecemberTwoThousandElevenFinancingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=stem_NovemberTwoThousandEightFinancingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=stem_NovemberTwoThousandNineFinancingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=stem_CaliforniaInstituteForRegenerativeMedicineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |